WORLD
CureVac COVID-19 Vaccine Records Only 48% Efficacy in Final Trial Readout ... - Latest Tweet by Reuters
The latest Tweet by Reuters states, 'CureVac COVID-19 vaccine records only 48% efficacy in final trial readout ...'
CureVac COVID-19 vaccine records only 48% efficacy in final trial readout https://t.co/ngGEd80yVK pic.twitter.com/NENxvCnZZ8— Reuters (@Reuters) July 1, 2021
(The above story first appeared on LatestLY on Jul 01, 2021 07:36 AM IST. For more news and updates on politics, world, sports, entertainment and lifestyle, log on to our website latestly.com).
